Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy

NCT: NCT05244486 · RECRUITING

NCT IDNCT05244486
StatusRECRUITING
Start Date2022-03-12
Completion2030-09-14
SponsorCharitable Union for the Research and Education of Peyronie's Disease (OTHER)
First posted
Last updated

Brief Summary

Evaluate the efficacy of the RestoreX penile traction device in preserving erectile function in men undergoing robotic-assisted prostatectomy. This study will evaluate men undergoing prostatectomy with bilateral nerve preservation and preserved baseline erectile function (moderate ED or better). The primary outcome will be changes in the IIEF-EFD scores between groups at 6 months. Secondary outcomes include differences in questionnaire outcomes at 3, 6, and 9 months.

Frequently Asked Questions

What is Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy?

Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy is a clinical trial registered under NCT05244486. Current status: RECRUITING.

What is the status of NCT05244486?

The current status of NCT05244486 (Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy) is: RECRUITING.

When did Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy start?

Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy started on 2022-03-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.